DOSAGE FORM
Film-coated tablets.
Main physicochemical properties: film-coated tablets of white or almost white color, round shape, with a biconvex surface, odorless or with a slight odor of ammonia.
COMPOSITION
active ingredient : bismuth subcitrate;
1 tablet contains 320 mg of bismuth subcitrate, which is equivalent to 120 mg of bismuth oxide;
excipients: corn starch, povidone, polacrilin potassium, magnesium stearate, coating mixture (polyethylene glycol, titanium dioxide (E 171), polyvinyl alcohol, talc).
PHARMACOTHERAPEUTIC GROUP
Drugs for the treatment of peptic ulcer and gastroesophageal reflux disease. Bismuth subcitrate
ATX code A02B X05.
INDICATIONS FOR USE
Gastric and duodenal ulcers, chronic gastritis, including those caused by Helicobacter pylori (as part of anti-Helicobacter therapy regimens).
Bismuth oxide
-
$41 -
Dosage form Tablets. Active ingredient 1 tablet contains bismuth nitrate basic, calculated on 282 mg of bismuth oxide – 350 mg, magnesium carbonate heavy, calculated on 168.5 mg of magnesium oxide – 400 mg, sodium hydrocarbonate – 200 mg, buckthorn bark powder – 25 mg, sweet flag root powder – 25 mg. Indications In the complex therapy of gastric ulcer and duodenal ulcer, functional dyspepsia, hyperacid gastritis.$11 -
Ulcavis: Exploring Medical Uses and Guidelines Medical Uses: Ulcavis, renowned for its ulcer-healing properties, is actively used in medical practice. Treatment of Gastric Ulcers: The medication is effective in treating gastric and duodenal ulcers. Prevention of Recurrences: Ulcavis can be used to prevent recurrences of ulcer-related conditions. Gastritis Management: It is used to manage symptoms of gastritis and other gastrointestinal disorders.$38